Medicaments; containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, (not packaged for retail sale)

HS code 300360 covers: Medicaments; containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, (not packaged for retail sale). This HS code covers bulk medicaments specifically containing antimalarial active principles, intended for therapeutic or prophylactic uses, but not yet packaged for retail sale. This means it's primarily raw or semi-finished pharmaceutical ingredients (APIs) or bulk formulations traded between pharmaceutical manufacturers, often for further processing, packaging, or distribution to global health programs. Key players in this trade include large pharmaceutical companies, generic drug manufacturers, and international aid organizations or NGOs focused on combating malaria. The trade is heavily influenced by global health initiatives, disease prevalence in tropical regions, and the need for affordable, effective treatments. Regulatory compliance and quality control are paramount, given the critical nature of these medicines. Understanding the specific active principle is crucial for correct classification, as this subheading is quite specific.

Artemether-lumefantrine bulk, Dihydroartemisinin-piperaquine bulk, Chloroquine phosphate API, Mefloquine hydrochloride API, Primaquine phosphate API, Atovaquone-proguanil bulk, Sulfadoxine-pyrimethamine bulk

This code can be confused with 300460 if the antimalarial medicament is already packaged for retail sale, or with Chapter 29 codes (e.g., 2939) if it's a pure, unformulated alkaloid before becoming a medicament.

HS code 300360 is a 6-digit subheading under the Harmonized System. The first 2 digits (30) identify the chapter, digits 3-4 (03) identify the heading, and digits 5-6 (60) specify the subheading. This code is standardized globally by the World Customs Organization.